🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)

Recruitingn/aAges 18 Years - anyAllAcute Leukemia French Association
NCT04777916 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

During the last fifteen years, the landscape of AML diagnosis and therapeutical options has markedly evolved. Refined genetic and prognostic characterizations, together with new drug approvals and new allogeneic hematopoietic stem cell transplantation (HSCT) procedures, have increased patient journey diversity.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient aged 18 years old or more * Patient with newly diagnosed previously untreated de novo, secondary or therapy-related AML * Patients with R/R de novo, secondary or therapy-related AML * Patient with Health insurance Exclusion Criteria: * Acute promyelocytic leukemia * AML which is not morphologically proven (patients with granulocytic sarcoma may be included) * For newly diagnosed AML: previous treatment of leukemia apart from hydroxyurea. Previous anti leukemia treatments are allowed if they were administered before the diagnosis of AML to treat a MDS, MPN, MPN/MDS or CML * Patient weighting less than 50 kgs * Opposition of the patient to participate to this non-interventional study More specific eligibility criteria might be requested to enter some study modules
💊

What it tests

  • Not listed
📍

Where

30 sites
Chu Amiens
Amiens, France
Centre Hospitalier Victor Dupouy
Argenteuil, France
AP-HP-GHU - Hôpital AVICENNE
Bobigny, France
CHU de la cote de Nacre
Caen, France
Hôpital MILITAIRE PERCY
Clamart, France
Centre hospitalier Sud Francilien
Corbeil-Essonnes, France
Hôpital Henri Mondor AP-HP
Créteil, France
CHU Dijon- François Mitterrand
Dijon, France

…and 22 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy